Anti-IL-6 Treatment for Migraine in Rheumatology Patients
Part of Brain & nervous system clinical trials.
This study checks whether anti-IL-6 medications (drugs that reduce a certain immune protein) can help reduce migraines in people who are already taking them for a rheumatological condition like rheumatoid arthritis. Researchers will compare people taking anti-IL-6 drugs with those taking a different type of biotherapy to see if one works better for migraine relief.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are at least 18 years old
- You have been taking anti-IL-6 or anti-TNF biotherapy for at least 3 months for a rheumatological condition (such as rheumatoid arthritis or similar)
- You have active migraines that meet official medical criteria for migraine diagnosis
- You are not being treated with biotherapy specifically for giant cell arteritis (a blood vessel inflammation condition)
- You can communicate verbally and understand French or speak French
- You are affiliated with the French national health insurance system
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests a new treatment (anti-CGRP antibodies) to prevent migraine attacks from becoming chronic. It looks at whether we can predict who will respond best, aiming to find better long-term control for people with frequent or chronic migraine.
This study looks at tear samples to find biomarkers that could help diagnose migraine. It involves people with migraine and healthy volunteers.
This trial tests whether a combination of physical therapy techniques can reduce migraine symptoms. It may help people whose migraines are not caused by other conditions.
This trial tests a substance that activates adrenomedullin receptors, which may be a new way to treat migraines. It may help people who have migraines without aura and aren't on preventive migraine medications.
This study tests whether a specific diet change can help reduce migraine frequency. Participants will follow a structured diet plan for several weeks to see if it leads to fewer headache days.
This study tests new ways to monitor how well preventive migraine treatments are working. It is for people with chronic migraine who may be starting or already using preventive medications.
Hear when a new Migraine trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.